NR1H4 and metabolic dysfunction-associated steatohepatitis: These two articles respectively discuss the relationship between the presence and severity of NASH and specific changes in circulating bile acids as well as the improvement of the histological characteristics of NASH by Farnesoid X nuclear receptor ligand obeticholicacid.